ClinConnect ClinConnect Logo
Search / Trial NCT04829617

Promoting Well-being and Health in Heart Failure

Launched by MASSACHUSETTS GENERAL HOSPITAL · Mar 31, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Positive Psychology Physical Activity Low Sodium Diet Medication Adherence Motivational Interviewing

ClinConnect Summary

This clinical trial is studying a new approach to help people with heart failure improve their well-being and health. Over 24 weeks, participants will receive support through phone calls and text messages designed to motivate them to stick to healthy habits, like following a proper diet and exercising. The trial compares this supportive program to a standard educational approach that also uses motivational interviewing techniques. Researchers want to see if the new program can help participants feel better and manage their heart failure more effectively.

To be eligible for the trial, participants should be adults aged 65 to 74 with heart failure classified as NYHA class I, II, or III, which means their condition varies from mild to moderate. They must also have difficulty following health recommendations, as defined by a specific scoring system. However, people who have cognitive issues that make it hard to understand the study, serious medical conditions, or those already involved in similar programs will not be able to participate. Participants can expect regular phone interactions and tailored text messages that encourage them to set and achieve their health goals. This study is currently recruiting, and it's a great opportunity for those looking to improve their heart health with guided support.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult patients with NYHA class I, II, or III HF.
  • Suboptimal adherence to health behaviors. This will be defined as a total score of ≤15 on three Medical Outcomes Study Specific Adherence Scale (MOS) items regarding diet/exercise/medications.
  • Exclusion Criteria:
  • Cognitive deficits impeding a participant's ability to provide informed consent or participate, assessed via a 6-item cognitive test.
  • Medical conditions likely to lead to death within 6 months.
  • Inability to participate in physical activity due to another medical condition (e.g., arthritis).
  • Inability to read, write, or speak in English.
  • Current participation in another intervention or program that has been designed to promote well-being or health behavior adherence.

About Massachusetts General Hospital

Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.

Locations

Boston, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Christopher M Celano, MD

Principal Investigator

Massachusetts General Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials